Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on L 1. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Discover 85% yield, room-temperature DBU-catalyzed indeno succinimide synthesis. Reduce costs, simplify scale-up, and ensure high purity for your drug development.
Solve N-acyl indole synthesis challenges with high-yield, one-step palladium-catalyzed method. Reduce costs and supply risks for drug development.
Solve high cost & safety risks in Baloxavir production. New route avoids chiral resolution, 98.7% ee, 84.5% yield. Scale to 100 MT/yr.
Discover a non-metal-catalyzed 1,2,4-triazole synthesis method that eliminates anhydrous conditions, cuts heavy metal waste, and ensures high-yield production for pharmaceutical intermediates. Reduce costs and de-risk your supply chain.
Solve high catalyst loading issues in asymmetric hydrogenation. Our CDMO expertise delivers 99% yield, 97% ee at 0.02 mol% catalyst for chiral APIs and flavors.
Solve supply chain risks with high-yield, atom-efficient diarylsultam synthesis. No pre-functionalization needed. Contact for custom manufacturing.
Eliminate CO gas handling risks and high costs in biheterocyclic synthesis. Discover scalable, high-yield routes for pharmaceutical intermediates with 99%+ purity.
Solve 2-pyrrolidone synthesis challenges with nickel-catalyzed method. High functional group tolerance, low cost, and scalable production for pharma R&D and procurement.
Solve harsh reaction challenges with this mild, copper-catalyzed method for trifluoromethyl dihydrofuran amines. High functional group tolerance ensures reliable supply for API synthesis.
Solve supply chain risks in trifluoromethyl imidazole production with this patent-validated method. Achieve 99% yields using cheap, scalable chemistry. Contact for CDMO solutions.
Discover how nickel/photo-redox catalysis enables 78-83% yield in C-H cross-coupling for pharmaceutical intermediates with 99:1 regioselectivity. Reduce production costs and supply chain risks.
Solve impurity E risks & cost issues in 3,5-dichlorobenzyl alcohol production. New method ensures >99.9% purity, 96% yield, and eliminates warning structure impurities for pharma supply chains.
Discover high-yield, enantioselective chiral indoloindolizidine synthesis with 97%+ ee. Solve supply chain risks for anti-cancer/antiviral drug development.
Solve supply chain risks with metal-free 5-trifluoromethyl-1,2,4-triazole synthesis. No catalysts, low cost, high yield. NINGBO INNO PHARMCHEM scales to 100 MT/yr.
Solve indole synthesis challenges with high-yield, cost-effective nickel-catalyzed carbonylation. Streamline your API production with scalable, functional-group-tolerant routes.
Solve acylation challenges with metal-free photochemistry: 72% yield, no expensive catalysts, and scalable production for drug development. Request a quote today.
Solve high-cost, low-yield issues in Ribociclib production. Our CDMO leverages patent-validated metal-free routes for 99.8% purity, 5-step synthesis, and scalable manufacturing.
Discover how photocatalytic synthesis of tetrahydrofuran indole compounds reduces production costs and improves yield for pharmaceutical intermediates. Contact us for custom synthesis solutions.
Discover a one-step, high-yield method for N-acyl indole synthesis with broad substrate tolerance. Reduce production costs and supply chain risks for pharmaceutical intermediates.
Solve 1,2,4-triazole-3-ketone synthesis challenges with palladium-catalyzed carbonylation. Reduce costs, improve yields, and ensure supply chain stability for pharmaceutical intermediates.